'You disappointed us': Why is Canada opposing more transparency in drug prices?
Monday, May 27, 2019 - 21:08
in Mathematics & Economics
Frustration at the pharmaceutical industry's high prices and secrecy bubbled over at the World Health Assembly this week as delegates fought for a strongly-worded resolution calling for greater transparency in the cost of clinical trials, drug R&D and prices. But some countries, including Canada, pushed for softer wording that could maintain secrecy in prices and research.